Abstract:BackgroundIn 2005, Ghana replaced chloroquine with artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria. The aim of this work was to determine for the first time, polymorphisms in the putative pfATPase6 and pftctp, pfmdr1, pfcrt genes in Ghanaian isolates, particularly at a time when there is no report on artemisinin resistance in malaria parasites from Ghana. The sensitivity of parasite isolates to anti-malaria drugs were also evaluated for a possible association with po… Show more
“…The four important SNPs in Pfatpase6 gene reported to be associated with artemisinin resistance in different studies are L263E, E431K, A623E, and S769N (Tahar et al 2009;Jambou et al 2010;Krishna et al 2010;Zakeri et al 2012). However, L263E was not observed in any of the field isolates in all the studies conducted so far (Kwansa-Bentum et al 2011;Tanabe et al 2011) but only detected in vitro (Uhlemann et al 2005). The studies on P. falciparum isolates from Suriname too revealed L263, A623, and S769 codons in Pfatpase6 gene to be wild type (Adhin et al 2012).…”
Section: Discussionmentioning
confidence: 73%
“…Also, in Southern-Iran, L263 and A623 were reported to be wild type (Zakeri et al 2012). The presence of S769N also made occasional impacts from few studies (Jambou et al 2005;Pillai et al 2012;Zakeri et al 2012) like that of the French Guiana (Legrand et al 2008) while there are reports which observed its absence in the P. falciparum isolates that were analyzed (Mugittu et al 2006;Sisowath et al 2007;Zhang et al 2008;Ferreira et al 2008;Menegon et al 2009;Wangai et al 2011;Kwansa-Bentum et al 2011;Tanabe et al 2011;Brasil et al 2012;Saha et al 2013) or even denied the association of this SNP with artemisinin resistance (Phompradit et al 2011;Cui et al 2012). Another study from Yaounde, Cameroon, where all these four mutations were tested, high prevalence of E431K was warranted and alarmed (Tahar et al 2009).…”
Antimalarial drug resistance including artemisinin resistance in Plasmodium falciparum malaria is a major concern in combating malaria throughout the world. Delayed parasite clearance time (PCT) is indicative of emergence of artemisinin resistance. Herein, PCT has been monitored with the help of gold standard technique microscopy accompanied by a more sensitive real-time assay for academic purpose. After the administration of artemisinin based combination therapy, artesunate + sulfadoxine pyrimethamine (AS + SP), all the subjects were followed up to day 42 for monitoring the therapeutic efficacy of AS + SP in Bisra Community Health Centre (CHC), Sundergarh district in the state of Odisha in India. Further, representative samples were analyzed for L263E, E431K, A623E and S769N SNPs in Pfatpase6 gene and copy number polymorphisms in Pfmdr1 gene. Though all the samples were found parasite negative according to microscopy by the end of day 3 and attained adequate clinical and parasitological response (ACPR) at the end of day 42, real-time PCR showed day 3 positivity in 12 of the total analyzed samples (n = 43). This was further validated by end-point diagnostic PCR and correlated with high initial parasite load. E431K mutation was observed in 2 of the 12 samples (16.7 %) while the controls (n = 18) were all wild. L263E, A623E and S769N were wild in all the analyzed samples (n = 30). Pfmdr1 copy number analysis showed no change in the said trait. Conclusively, real-time PCR could support microscopy for better monitoring of PCT and may provide as an additional but useful research tool for artemisinin resistance studies.
“…The four important SNPs in Pfatpase6 gene reported to be associated with artemisinin resistance in different studies are L263E, E431K, A623E, and S769N (Tahar et al 2009;Jambou et al 2010;Krishna et al 2010;Zakeri et al 2012). However, L263E was not observed in any of the field isolates in all the studies conducted so far (Kwansa-Bentum et al 2011;Tanabe et al 2011) but only detected in vitro (Uhlemann et al 2005). The studies on P. falciparum isolates from Suriname too revealed L263, A623, and S769 codons in Pfatpase6 gene to be wild type (Adhin et al 2012).…”
Section: Discussionmentioning
confidence: 73%
“…Also, in Southern-Iran, L263 and A623 were reported to be wild type (Zakeri et al 2012). The presence of S769N also made occasional impacts from few studies (Jambou et al 2005;Pillai et al 2012;Zakeri et al 2012) like that of the French Guiana (Legrand et al 2008) while there are reports which observed its absence in the P. falciparum isolates that were analyzed (Mugittu et al 2006;Sisowath et al 2007;Zhang et al 2008;Ferreira et al 2008;Menegon et al 2009;Wangai et al 2011;Kwansa-Bentum et al 2011;Tanabe et al 2011;Brasil et al 2012;Saha et al 2013) or even denied the association of this SNP with artemisinin resistance (Phompradit et al 2011;Cui et al 2012). Another study from Yaounde, Cameroon, where all these four mutations were tested, high prevalence of E431K was warranted and alarmed (Tahar et al 2009).…”
Antimalarial drug resistance including artemisinin resistance in Plasmodium falciparum malaria is a major concern in combating malaria throughout the world. Delayed parasite clearance time (PCT) is indicative of emergence of artemisinin resistance. Herein, PCT has been monitored with the help of gold standard technique microscopy accompanied by a more sensitive real-time assay for academic purpose. After the administration of artemisinin based combination therapy, artesunate + sulfadoxine pyrimethamine (AS + SP), all the subjects were followed up to day 42 for monitoring the therapeutic efficacy of AS + SP in Bisra Community Health Centre (CHC), Sundergarh district in the state of Odisha in India. Further, representative samples were analyzed for L263E, E431K, A623E and S769N SNPs in Pfatpase6 gene and copy number polymorphisms in Pfmdr1 gene. Though all the samples were found parasite negative according to microscopy by the end of day 3 and attained adequate clinical and parasitological response (ACPR) at the end of day 42, real-time PCR showed day 3 positivity in 12 of the total analyzed samples (n = 43). This was further validated by end-point diagnostic PCR and correlated with high initial parasite load. E431K mutation was observed in 2 of the 12 samples (16.7 %) while the controls (n = 18) were all wild. L263E, A623E and S769N were wild in all the analyzed samples (n = 30). Pfmdr1 copy number analysis showed no change in the said trait. Conclusively, real-time PCR could support microscopy for better monitoring of PCT and may provide as an additional but useful research tool for artemisinin resistance studies.
“…The 68 pfatp6 sequences recently obtained in southern Ghanaian samples were partial sequences and were excluded in our analysis [54]. Comparison of all pfatp6 sequences identified a total of 71 SNPs, including 30 synonymous and 41 non-synonymous.…”
The recent detection of clinical Artemisinin (ART) resistance manifested as delayed parasite clearance in the Cambodia-Thailand border area raises a serious concern. The mechanism of ART resistance is not clear; but the P. falciparum sarco/endoplasmic reticulum Ca2+-ATPase (PfSERCA or PfATP6) has been speculated to be the target of ARTs and thus a potential marker for ART resistance. Here we amplified and sequenced pfatp6 gene (∼3.6 Kb) in 213 samples collected after 2005 from the Greater Mekong Subregion, where ART drugs have been used extensively in the past. A total of 24 single nucleotide polymorphisms (SNPs), including 8 newly found in this study and 13 nonsynonymous, were identified. However, these mutations were either uncommon or also present in other geographical regions with limited ART use. None of the mutations were suggestive of directional selection by ARTs. We further analyzed pfatp6 from a worldwide collection of 862 P. falciparum isolates in 19 populations from Asia, Africa, South America and Oceania, which include samples from regions prior to and after deployments ART drugs. A total of 71 SNPs were identified, resulting in 106 nucleotide haplotypes. Similarly, many of the mutations were continent-specific and present at frequencies below 5%. The most predominant and perhaps the ancestral haplotype occurred in 441 samples and was present in 16 populations from Asia, Africa, and Oceania. The 3D7 haplotype found in 54 samples was the second most common haplotype and present in nine populations from all four continents. Assessment of the selection strength on pfatp6 in the 19 parasite populations found that pfatp6 in most of these populations was under purifying selection with an average dN/dS ratio of 0.333. Molecular evolution analyses did not detect significant departures from neutrality in pfatp6 for most populations, challenging the suitability of this gene as a marker for monitoring ART resistance.
“…Concerns about artemisinin resistance have been reported recently [22], and all malaria-endemic countries have been warned to be more vigilant in monitoring antimalarial drug efficacy, to allow the early detection of artemisinin resistance and aid global malaria control [23][24][25]. Furthermore, most rapid diagnostic test kits currently available on the market are based on HRPII and pLDH (as a biomolecule).…”
Malaria continues to be a devastating disease. In a previous study, we formulated a chemically defined culture medium that is able to sustain the complete intraerythrocytic growth of Plasmodium falciparum. We tested the feasibility of using the medium (CDRPMI) as well as human serum-free media enriched with commercially available human-serum substitutes (GFSRPMI and ALBRPMI) to assess the drug sensitivity of P. falciparum, using chloroquine diphosphate (CQ) and dihydroartemisinin (DHART) as conventional antimalarial drugs. Growth inhibition was measured by four different methods: flow cytometry with SYBR Green I (FCM), microscopy (Giemsa method), enzymatic estimation of parasite lactate dehydrogenase (pLDH), and histidine-rich protein 2 (HRPII) determination. In drug sensitivity tests on asynchronous parasites cultured for 96 h in the presence of drugs, the dose-response curves were similar and differences in the 50% growth inhibition concentrations for the drugs, which were estimated by the four methods, were not statistically significant for the three culture media. The effect of the drugs on the growth of synchronous parasites at the ring stage was also assessed in micro-volume tests by three different methods of FCM: tracking fluorescent erythrocytes, schizont test, and merozoite test. Dose-response curves for the drugs were similar, and differences in the 50% growth inhibition concentrations were not statistically significant for CDRPMI and GFSRPMI.Thus CDRPMI as well as GFSRPMI and ALBRPMI can be similarly useful media for drug sensitivity testing of P. falciparum. The FCM, pLDH and HRPII estimations were fast and reliable detection methods, with FCM allowing schizont and merozoite tests to be performed with shorter periods of culture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.